Loading
A phase 3 trial of topotecan in lung cancer, run by JenKem Technology Co., Ltd., not yet recruiting.
JK-1201I Compared with Topotecan in Patients with Relapsed Extensive Stage Small Cell Lung Cancer is a phase 3, randomised interventional study registered as NCT06581380 by JenKem Technology Co., Ltd., with a registry enrolment figure of 394 participants, started 2024-09-16 and due to reach its primary completion in 2027-11-16. Interventions recorded: JK-1201I; Topotecan. Conditions listed: Small Cell Lung Cancer. Primary outcome: Overall survival (OS). Lung eligibility wording from the registry: "Histologically or cytologically documented SCLC". No results are recorded here; the registry entry is the source.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Topotecan, Extensive-stage small-cell lung cancer, Topoisomerase-I inhibitors (and ADC payloads), Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Topoisomerase-I inhibitors (and ADC payloads), Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Topoisomerase-I inhibitors (and ADC payloads), Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Topoisomerase-I inhibitors (and ADC payloads), Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Topoisomerase-I inhibitors (and ADC payloads), Lung cancer trials open today (registry snapshot), Cytotoxic chemotherapy and the tag lung-deep-dive.
Shares Extensive-stage small-cell lung cancer, Lung cancer trials open today (registry snapshot) and the tag lung-deep-dive.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/